Protective effect of Ulinastatin against murine models of sepsis: Inhibition of TNF-α and IL-6 and augmentation of IL-10 and IL-13

References

Page 1

	Year	Citations
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care Derek C. Angus, Walter T. Linde‐Zwirble, Jeffrey Lidicker, Critical Care Medicine	2001	8.5K
The Epidemiology of Sepsis in the United States from 1979 through 2000 Greg S. Martin, David M. Mannino, Stephanie Eaton, New England Journal of Medicine	2003	5.8K
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock R. Phillip Dellinger, Jean Carlet, Henry Masur, Intensive Care Medicine Trauma ResuscitationCritical Care ManagementSevere SepsisAcute CarePatient Safety	2004	3.3K
Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock R. Philip Dellinger Critical Care Medicine Critical Care ManagementSevere SepsisAcute CarePatient SafetyOutcomes Research	2004	1.9K
ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE Anders Waage, Alfred Halstensen, Terje Espevik The Lancet InflammationClinical EpidemiologyImmunologyPathologySepsis	1987	1.1K
Sir Isaac Newton, sepsis, SIRS, and CARS R C Bone Critical Care Medicine Philosophy Of MedicineHumanitiesSir Isaac NewtonMedical HistoryThanatology	1996	987
Serum Cytokine Levels in Human Septic Shock Michael R. Pinsky, Jean‐Louis Vincent, Jacques Devière, CHEST Journal InflammationCytokineSerum Cytokine LevelsImmunologyInflammatory Marker	1993	885
Pro‐ versus Anti‐inflammatory Cytokine Profile in Patients with Severe Sepsis: A Marker for Prognosis and Future Therapeutic Options Charalambos Gogos, Eugenia Drosou, Harry P. Bassaris, The Journal of Infectious Diseases InflammationSoluble Tnf ReceptorsCytokineSevere SepsisAnti-inflammatory Cytokine Il-10	2000	868
Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Kimberly J. Van Zee, Tadahiko Kohno, E Fischer, Proceedings of the National Academy of Sciences ImmunologyImmune RegulationPathologyCell DeathClinical Inflammation	1992	851
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity PIERRE DAMA, Didier Ledoux, Monique Nys, Annals of Surgery InflammationCytokineHuman Il-6Severe SepsisIntensive Care Unit	1992	802

Page 1